Kevin Friedman Do

Kevin Friedman, DO, currently serves as Chief Medical Officer at Nutromics since August 2024 and as Medical Director, Head of Medical Affairs and Pharmacovigilance at VERO Biotech since May 2023. Friedman operates a medical consulting firm, Friedman Physician Consulting, PC, established in January 2020. Previous roles include Medical Director for Medical Safety and Vigilance at embecta from April 2022 to May 2023, and Senior Director Global Medical Affairs at BD from August 2019 to April 2022. Additional experience includes Medical Director positions at Owens & Minor, Halyard Health, and Avanos Medical during their respective transitions. Friedman holds a Doctor of Osteopathic Medicine from Nova Southeastern University and is pursuing a Master of Science in Global Clinical and Pharmacovigilance Regulations at Temple University.